1.
Clin Infect Dis
; 78(1): 27-30, 2024 01 25.
Article
in English
| MEDLINE
| ID: mdl-37584360
ABSTRACT
In a propensity-score-weighted cohort of 183 adults with carbapenem-resistant Enterobacterales bacteremia at 24 US hospitals, patients receiving short courses of active therapy (7-10 days, median 9 days) experienced similar odds of recurrent bacteremia or death within 30 days as those receiving prolonged courses of active therapy (14-21 days, median 14 days).